Amy's Buyout: Entrepreneurship Through Acquisition (A) Custom Case Solution & Analysis

Evidence Brief

Financial Metrics

Purchase Price: 4,500,000 dollars.
Adjusted EBITDA: 1,125,000 dollars based on the most recent fiscal year.
Implied Valuation Multiple: 4.0x EBITDA.
Proposed Debt Structure: 3,000,000 dollars in senior debt via SBA 7a loan; 500,000 dollars in a seller note.
Equity Requirement: 1,000,000 dollars from Amy and her search fund investors.
Working Capital: 450,000 dollars required at closing to maintain operations.
Profit Margins: Consistent net margins of 18 percent over the last three fiscal years.

Operational Facts

Headcount: 22 full-time employees; 15 in production, 4 in administration, 3 in sales.
Facility: 15,000 square foot leased manufacturing space in the Midwest.
Customer Concentration: Top three customers account for 42 percent of total annual revenue.
Product Range: Specialized precision components for the medical device industry.
Supply Chain: Raw materials sourced from four primary vendors; no single vendor accounts for more than 30 percent of spend.
Owner Involvement: The current owner manages all top-tier customer relationships and oversees final quality control.

Stakeholder Positions

Amy: Post-MBA searcher seeking a stable platform with growth potential; primary concern is the debt service coverage ratio.
Mr. Sterling (Seller): Seeking full exit within 12 months to retire; prefers cash at closing over earn-outs.
Investors: Require a 25 percent Internal Rate of Return; concerned about the transition of technical knowledge.
Senior Lender: Requires a 1.25x debt service coverage ratio and a personal guarantee from Amy.

Information Gaps

Customer Contracts: The case does not specify if contracts contain change-of-control clauses.
Employee Retention: No data on the average tenure of the 15 production staff members.
Capital Expenditure: The age and remaining useful life of primary manufacturing machinery are not detailed.
Backlog: Current order book depth beyond the next 60 days is unstated.

Strategic Analysis

Core Strategic Question

Does the stability of the cash flows of the company justify the concentration risk and the total reliance on the personal relationships of the seller?

Structural Analysis

Bargaining Power of Buyers: High. The 42 percent concentration among three clients gives buyers significant pricing power and creates a binary risk if one exits.
Threat of Substitutes: Low. The precision nature of the components and the regulatory requirements in the medical device sector create high switching costs for customers.
Internal Value Chain: The primary value resides in the quality control process and the specialized knowledge of the production team. The sales process is currently a bottleneck residing solely with the owner.

Strategic Options

Option 1: Proceed with Structured Acquisition.
- Rationale: The 4x multiple is attractive for a high-margin business in a defensive industry.
- Trade-offs: High personal financial risk for Amy; immediate pressure to institutionalize sales.
- Resource Requirements: 1,000,000 dollars in equity and a 12-month transition agreement with the seller.
Option 2: Negotiate a Performance-Based Earn-out.
- Rationale: Mitigates the risk of customer churn following the departure of the owner.
- Trade-offs: May alienate the seller who prefers a clean exit; complicates the capital structure.
- Resource Requirements: Legal restructuring of the purchase agreement to tie 20 percent of the price to customer retention.
Option 3: Terminate the Deal.
- Rationale: The concentration risk and owner-dependence may be insurmountable for a first-time CEO.
- Trade-offs: Sunk costs of the search process; loss of a high-margin opportunity.
- Resource Requirements: None; resume the search for a more diversified target.

Preliminary Recommendation

Proceed with Option 1. The defensive nature of the medical device industry and the high margins provide a sufficient buffer for the debt service. The focus must immediately shift from deal-making to relationship institutionalization.

Implementation Roadmap

Critical Path

Phase 1: Financial and Legal Closing (Days 1 to 30). Finalize SBA loan documentation; execute the purchase agreement; secure key man insurance for Amy and the seller.
Phase 2: Relationship Transfer (Days 31 to 90). Conduct joint visits with the seller to the top five customers; document all informal pricing agreements and specifications.
Phase 3: Operational Stabilization (Days 91 to 180). Appoint a Lead Production Manager to handle quality control; implement a basic CRM system to track customer interactions.

Key Constraints

Knowledge Transfer: The technical expertise of the seller is not currently documented; loss of this data during the transition would halt production.
Debt Covenants: The 1.25x coverage ratio leaves little room for revenue decline; a 15 percent drop in sales would trigger a default.
Staff Culture: The transition from a family-run style to an MBA-led professional structure may cause friction among long-tenured employees.

Risk-Adjusted Implementation Strategy

The strategy assumes a 12-month transition. To mitigate the risk of seller disengagement, 250,000 dollars of the seller note will be contingent on the seller completing 500 hours of documented training and client introductions. This ensures the seller remains incentivized to pass on the secret sauce of the business.

Executive Review and BLUF

BLUF

Acquire the company at the 4,500,000 dollar valuation. The 18 percent net margins and the specialized medical niche provide a durable cash flow profile that justifies the 4.0x multiple. The primary threat is not market competition but the concentration of customer relationships in the hands of the seller. This is a manageable execution risk provided the transition period is strictly governed by a performance-linked seller note. Success depends on the ability of Amy to shift from an external buyer to a trusted partner for the top three clients within the first 100 days. The financial margin of safety is tight but sufficient for a disciplined operator.

Dangerous Assumption

The analysis assumes that the top three customers stay because of the product quality rather than personal loyalty to Mr. Sterling. If the loyalty is personal, the 42 percent revenue block is at immediate risk regardless of the transition plan.

Unaddressed Risks

Regulatory Shift: A change in medical device certification standards could require immediate capital expenditure for new machinery, depleting the thin cash reserves.
Interest Rate Volatility: Since the SBA loan is variable, a 200-basis point increase in rates would compress the debt service coverage ratio to near-default levels.

Unconsidered Alternative

The team did not evaluate a phased equity buy-in. Amy could acquire 51 percent now and the remaining 49 percent after two years. This would keep the seller fully committed to the long-term success and growth of the firm while reducing the initial debt burden on Amy.